Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia

A Bartoloni1, F Cutts, S Leoni

  • 1Clinica Malattie Infettive, Università di Firenze, Italy. infdis@cesit1.unifi.it

Insights

Antimicrobial-resistant E. coli is common in healthy children in Bolivia, with high rates of resistance to ampicillin and trimethoprim-sulphamethoxazole (TMP/SMX). This widespread resistance in healthy individuals poses a global threat to antimicrobial therapy effectiveness.

Area of Science:

  • Microbiology
  • Public Health
  • Infectious Diseases

Background:

  • Antimicrobial resistance (AMR) is a growing global health concern.
  • Nonpathogenic bacteria can carry resistance genes, contributing to the overall AMR burden.
  • Understanding AMR prevalence in healthy populations is crucial for public health strategies.

Purpose of the Study:

  • To determine the incidence of antimicrobial-resistant, nonpathogenic Escherichia coli (E. coli) in healthy children in south-eastern Bolivia.
  • To investigate antimicrobial availability and usage patterns in Camiri town.

Main Methods:

  • Community-based survey of stool samples from healthy children aged 6-72 months in Camiri and Javillo, Bolivia.
  • Antimicrobial susceptibility testing of E. coli isolates using the disc diffusion method.
  • Questionnaire survey and simulated patients study to assess antimicrobial availability and usage patterns.

Main Results:

  • Over 90% of children in Camiri and over 70% in Javillo carried E. coli resistant to ampicillin, trimethoprim-sulphamethoxazole (TMP/SMX), or tetracycline.
  • 63% of children carried E. coli with multidrug resistance to ampicillin, TMP/SMX, tetracycline, and chloramphenicol.
  • Inappropriate antimicrobial dispensing was observed in 92% of adults and 40% of children for watery diarrhea, with under-dosing common.

Conclusions:

  • A high prevalence of antimicrobial-resistant nonpathogenic E. coli carriage was found in healthy children in Bolivia.
  • Resistance rates to ampicillin and TMP/SMX exceeded those previously reported in developing countries.
  • The large reservoir of resistance genes in healthy individuals in developing nations threatens global antimicrobial therapy success, necessitating improved drug use programs.
Abstract

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...